 |
|---|
| As Of | Filer | Filing¹ | For·On·As | Docs:Size | Issuer | | Filing Agent | | | | | | | | | |
|---|
|
|---|
3/17/22 Joshi Abhay 4 Officer² 1:5K Revance Therapeutics, Inc. DONNELLEY FIN… File16/FA
2/17/22 Joshi Abhay 4 Officer² 2:9K Revance Therapeutics, Inc. Revance Theraps, Inc.
3/17/21 Joshi Abhay 4 Officer² 1:4K Revance Therapeutics, Inc. Revance Theraps, Inc.
2/19/21 Joshi Abhay 4 Officer² 1:6K Revance Therapeutics, Inc. Revance Theraps, Inc.
2/4/21 Joshi Abhay 4 Officer² 1:6K Revance Therapeutics, Inc. Revance Theraps, Inc.
10/2/20 Joshi Abhay 4 Officer² 1:5K Revance Therapeutics, Inc. Workiva Inc Wde… FA01/FA
3/17/20 Joshi Abhay 4 Officer² 1:5K Revance Therapeutics, Inc. DONNELLEY FIN… File16/FA
2/19/20 Joshi Abhay 4 Officer² 1:5K Revance Therapeutics, Inc. Revance Theraps, Inc.
1/24/20 Joshi Abhay 4 Officer² 1:6K Revance Therapeutics, Inc. Revance Theraps, Inc.
1/17/20 Joshi Abhay 4 Officer² 1:4K Revance Therapeutics, Inc. Revance Theraps, Inc.
12/17/19 Joshi Abhay 4 Officer² 1:4K Revance Therapeutics, Inc. Revance Theraps, Inc.
3/18/19 Joshi Abhay 4 Officer² 1:8K Revance Therapeutics, Inc. Revance Theraps, Inc.
2/20/19 Joshi Abhay 4 Officer² 1:4K Revance Therapeutics, Inc. Revance Theraps, Inc.
1/25/19 Joshi Abhay 4 Officer² 1:6K Revance Therapeutics, Inc. Revance Theraps, Inc.
1/17/19 Joshi Abhay 4 Officer² 1:4K Revance Therapeutics, Inc. Revance Theraps, Inc.
12/14/18 Joshi Abhay 4 Officer² 1:4K Revance Therapeutics, Inc. Revance Theraps, Inc.
3/23/18 Joshi Abhay 4 Officer² 1:5K Revance Therapeutics, Inc. Revance Theraps, Inc.
2/16/18 Joshi Abhay 4 Officer² 1:4K Revance Therapeutics, Inc. Revance Theraps, Inc.
2/9/18 Joshi Abhay 4 Officer² 1:6K Revance Therapeutics, Inc. Revance Theraps, Inc.
1/17/18 Joshi Abhay 4 Officer² 1:5K Revance Therapeutics, Inc. Revance Theraps, Inc.
| ____________ | | ¹ | Filing/Form Type: /A | | 4 | Statement of Changes in Beneficial Ownership of Securities by an Insider — Form 4 { The Filer is an Insider² of the Issuer }. | | ² | Insider: The Filer is a Director, Officer, 10% Owner and/or Other “insider” of the Issuer. |
|
